DrugPatentWatch Database Preview
Patent: 8,414,895
» See Plans and Pricing
Summary for Patent: 8,414,895
| Title: | Tweak receptor |
| Abstract: | The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue. |
| Inventor(s): | Kim; Kristine M. (Mill Creek, WA), Wiley; Steven R. (Seattle, WA), Ketchem; Randal R. (Snohomish, WA), Fanslow, III; William C. (Normandy Park, WA) |
| Assignee: | Immunex Corporation (Thousand Oaks, CA) |
| Application Number: | 12/899,397 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,414,895
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Immunex Corporation (Thousand Oaks, CA) | 2020-12-19 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,414,895
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 0145730 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006047172 | Start Trial |
| United States of America | 2002041876 | Start Trial |
| United States of America | 2002110853 | Start Trial |
| United States of America | 2004253610 | Start Trial |
| United States of America | 2005208046 | Start Trial |
| United States of America | 2006084143 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
